Balansag, Christyl Mae S.
HRN: 07-64-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2022
CEFAZOLIN 1GM (VIAL)
08/02/2022
08/09/2022
IV
630mg
Q6h
Open Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes